VIDA Diagnostics

VIDA Diagnostics

Private
Coralville, IowaHealthcare & Life Scienceshttps://vidalung.ai/

Last Round

Debt

Jul 24, 2023

Total Funding Raised

$23.67M

Momentum Score

25 /100

Company Overview

VIDA Diagnostics is a healthtech company that provides an AI-powered clinical imaging intelligence platform and services to accelerate the development of therapies for lung, cardiac, and oncology indications.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

medical imaging AIclinical trial imagingdigital biomarkersquantitative imagingimaging CROlung imaging analysisrespiratory clinical trialsclinical trial softwarepulmonary imagingclinical decision supportcontract research organizationCROCOPD analysislung cancer screeningbronchoscopy planning

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VIDA Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VIDA Diagnostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtJul 24, 2023
Series C ExtensionApr 15, 2020
Series CMar 12, 2020
StrategicJul 25, 2019
Series BDec 20, 2016
Grant
Dec 1, 2016

Key People

Founding team and executive leadership

Carla Pacheco

CEO

Executive Team

Susan Wood

President And CEO

Executive Team

VIDA Diagnostics Investors

Notable investors and investment history

InvestorRounds
National Cancer InstituteGrant
First AnalysisSeries C
NIH RADxGrant
UnityPoint Health VenturesSeries C, Strategic
OSF VenturesSeries C, Series C Extension
Blue Heron CapitalSeries C
The Angels’ ForumSeries C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 39% MoM.

  • Feb 26, 2025

    Monthly visitors grew 58% MoM, reaching 36.5K.

VIDA Diagnostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VIDA Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VIDA Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCoralville, Iowa
Employee Range1,243
Year Founded2005
Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.